Press Releases

iCAD Inc. a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer today announced that the company received U.S. Food and Drug Administration (FDA) clearance for its new cervical applicator for...

The 10th edition of BioAsia, BioAsia 2013, Asia’s biggest technology and bio-business platform, which commenced on 28th January 2013 concluded on Wednesday. The valedictory ceremony was attended by eminent personalities including Dr. D. Purandeswari,...

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins announces today the  phase III development program of its product, BioChaperone(R) PDGF-BB for the treatment of diabetic foot ulcer (DFU). ...

  Athena Diagnostics a leader in neurological diagnostics today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders including hereditary neuropathy neuromuscular disease epilepsy and certain movement disorders. ...

The next generation of advanced pharmaceutical technologies could be poised to fuel remarkable growth in the $60 billion global drug delivery market and Rainbow Biosciences—the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC)—plans to be right in the middle...

Trio Clinical Resourcing an international biopharmaceutical and medical device resourcing company and a wholly owned subsidiary of Aptiv Solutions announced today the launch of its new company website at www.trioclinical.com. The new website is designed and updated with...

STENTYS (FR0010949404 – STNT) a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI) announced today one-year results of the APPOSITION III clinical trial in 1000 patients post...